Teraplast Sa (0JG3) 뉴스

Someone please pin this post. This is bang on. Thank you 

% # Of Wins For December

Commentary: Hope Everyone enjoys these statistics
[pre]
Alias # Of Wins % Of Wins
NO WINNER 4 40.00%
BULLNBEAR52 3 30.00%
SSKILLZ1 3 30.00%
Totals 10 100.00%
[/pre]

Word to the wise: If Tesla can double in 2 months, anything can and will happen!

“And your accreditation is…?”
Answer? Miro.

Maybe, maybe not.
Mushbrain claims he wants to get rid of fdic. So when he gets challenged, what is his actual plan? Like, "okay I won't shut it down now, but I'll have a crypto coin active for 6 months and then shut it down because crypto is better".

I can't shake how some of

If Tesla can double in 2 months, anything can and will happen!

~~COMPX 12/16/2024~~~~~~~

Previous Close

19,926.72 +23.88

19799 SSKILLZ1

By the way, added to the NASDAQ 100 for a nice pop and rip on Monday

At Sept. 30 Cash Equivalents = $262,141,000

Weighted-average common shares outstanding, basic and diluted 118,700,362

Cash value per share at Sept. 30/24 = $2.21

That value will continue to fall as a function of time, only income is collaborative revenue

Trump’s ‘power move’ fizzles as China’s Xi blows off inauguration
https://www.rawstory.com/wants-a-global-stage-trumps-power-move-fizzles-as-chinas-xi-blows-off-inauguration/

The Seeking Alpha article titled "Betting Big On AbbVie: A Prescription For Growth And Dividends has a good" has a good graphics of the Patent Cliff big pharma's are experiencing.

I did not realize that Merck was $33.9 Billion of revenue were at risk to patent expiration in 2028 (Keyt

.10 target, .02 min, we are about to see another 2021 type run for OTC imo, i'm feelin deja-vu!

"LQMT Valencia has no skin in the game and none of this affects the Company." Right, on paper, but none of this affects the company? Here is the problem, Bob.
It is arguably not an arm's length transaction if LL's Hong Kong shares are involved given his acknowledged conflicts of interest a

HIRU management reports a consultancy with a worldwide well-known consultancy with 7000 staff. Jack_Herer poster credential is better said, 'Not Applicable:" Likely with basis in internal reasons.

This week's Annovis CC revealed that the FDA still requires 2 co-primary endpoints for upcoming confirmatory p3 early AD trials for small-molecule candidates. However, the ADCS-ADL+ADAD-Cog13 co-primary endpoints are replaced by ADCS-iADL+ADAD-Cog13, and biomarker vMRI is agreed on for disease-modif

Targeting .0048 here, .0034 min imo, GL

My apologies to the board, I really butchered the name...
Palestinians is the correct spelling.

Hedera Empowers Zoniqx to Transform Real-World Asset Ownership with Blockchain
[pre]By GODFREY BENJAMIN12. December 2024Edited by ALEX MORRISON 12. December 2024[/pre]
*Tokenization platform Zoniqx taps Hedera to drive its tokenization agenda.
*The duo has a strong focus on sust

Small consolation given the amount the 3 amigos (and their families) took from investors based on their continued lies.

Trash like Mark, George and Raj can't be disgraced. They have no moral compass and are beyond contempt.

They got away with everything.

Thankfully my average is so low that I should be good. The way its looking is this should move from hype and maybe the merger news. Theres obviously a bunch of money to be made here but thank you for what you posted

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
Download as PDF
December 13, 2024
UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma

WALTHAM, Mass., Dec. 13, 2024 (GLOBE NE

You mean like this guy? FBI Assistant Director?

https://i.pinimg.com/736x/6d/a3/ba/6da3ba2f9510a28b047d7bf876cdc371.jpg

Never underestimate an OTC at a time when everything is melting up!